Assay News and Research

RSS
SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

SARS-CoV-2 breakthrough infection leads to distinct neutralizing antibody response

Delta and Omicron coinfections identified in France

Delta and Omicron coinfections identified in France

Identification of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding

Identification of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding

Binding efficacy of SARS-CoV-2 S1 specific salivary antibodies to the Omicron and Delta variants

Binding efficacy of SARS-CoV-2 S1 specific salivary antibodies to the Omicron and Delta variants

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

COVID-19 and the life sciences; what have we learned and where are we going?

COVID-19 and the life sciences; what have we learned and where are we going?

Lipidomic profiling may provide early prediction of type 2 diabetes and cardiovascular disease risk

Lipidomic profiling may provide early prediction of type 2 diabetes and cardiovascular disease risk

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

World's first Microhub makes spatial context accessible for all

World's first Microhub makes spatial context accessible for all

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Dual therapeutic potential of zapnometinib against COVID-19

Dual therapeutic potential of zapnometinib against COVID-19

The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Study explores dictionary learning-based bridge integration method for data harmonization of single-cell analysis

Study explores dictionary learning-based bridge integration method for data harmonization of single-cell analysis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.